TITLE

Streptococcus suis: An Emerging Human Threat

AUTHOR(S)
Segura, Mariela
PUB. DATE
January 2009
SOURCE
Journal of Infectious Diseases;1/1/2009, Vol. 199 Issue 1, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on the relevance of the streptococcus suis infection in humans. She mentions that streptococcus suis is an encapsulated Gram-positive coccus possessing cell-wall antigens related to Lancefield group D. She further mentions that in humans, streptococcus usually produces a purulent or nonpurulent meningitis.
ACCESSION #
36347906

 

Related Articles

  • Mapping of monoclonal antibodies specific to P64k: A common antigen of several isolates of Neisseria meningitidis. Nazábal, C; Carmenate, T; Cruz, S; González, S; Silva, R; Musacchio, A; Delgado, M; Chinea, G // Canadian Journal of Microbiology;Feb2001, Vol. 47 Issue 2, p158 

    P64k is a minor outer membrane protein from Neisseria meningitidis. This protein has been produced at high levels in Escherichia coli. We generated a group of monoclonal antibodies (mAbs) against recombinant P64k, which recognise four non-overlapping epitopes, as shown using competition assays...

  • Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients. Meerveld-Eggink, A.; Weerdt, O.; Voer, R. M.; Berbers, G. A. M.; van Velzen-Blad, H.; Vlaminckx, B. J.; Biesma, D. H.; Rijkers, G. T. // European Journal of Clinical Microbiology & Infectious Diseases;May2011, Vol. 30 Issue 5, p611 

    The purpose of this study was to determine the quantity and quality of antibodies against the meningococcal serogroup C (MenC) conjugated vaccine in asplenic patients. In 116 asplenic patients, antibody concentrations (IgG) were measured against meningococcal serogroup C before and after...

  • CROSS-REACTIVE ACTIVITY OF ANTIMENINGOCOCCAL HUMAN IMMUNOGLOBULIN AGAINST DIFFERENT NEISSERIA MENINGITIDES GROUP B SEROTYPES. A., Balboa J.; I., Martinez; A., Camaraza M.; M., Gutierrez; N., Iglesias; G., Sierra; C., Campa // Revista VacciMonitor (Vacunología y Temas Afines);Oct2002, Vol. 11 Issue 4, p1 

    Antimeningococcal Human Immunoglobulin (AHI) is derived from the blood plasma of healthy adult human donors who have been immunized with the Cuban antimeningococcal BC Vaccine. Previously, we demonstrated that this hyperimmune immunoglobulin has a titer at least of 1:64 for bactericidal activity...

  • Serological Correlates of Protection against Meningococci in a Cohort of University Students, before and during an Outbreak of Serogroup C Infection. Williams, Jeannette N.; Jones, Graeme R.; Christodoulides, Myron; Heckels, John E. // Journal of Infectious Diseases;5/1/2003, Vol. 187 Issue 9, p1433 

    Studies the association between individual meningococcal antigens and the development of protective immunity to both serogroup C and B meningococci before and during an outbreak of serogroup C infection among university students. Levels of bactericidal activity against the outbreak strain;...

  • Storage and stability of IgG and IgM monoclonal antibodies dried on filter paper and utility in Neisseria meningitidis serotyping by Dot-blot ELISA. Ferraz, Aline S.; Belo, Elza F. T.; Coutinho, Ligia M. C. C.; Oliveira, Ana P.; Carmo, Andréia M. S.; Franco, Daniele L.; Ferreira, Tatiane; Yto, André Y.; Machado, Marta S. F.; Scola, Monica C. G.; De Gaspari, Elizabeth // BMC Infectious Diseases;2008, Vol. 8 Issue 1, Special section p1 

    Background: A simple filter paper method was developed for, the transport and storage of monoclonal antibodies (Mabs) at room temperature or -20°C after spotting on filter paper, for subsequent sero-typing of outer membrane antigens of N.meningitidis by dot-blot ELISA. Methods: Monoclonal...

  • The formyl peptide receptor like-1 and scavenger receptor MARCO are involved in glial cell activation in bacterial meningitis. Braun, Benedikt J.; Slowik, Alexander; Leib, Stephen L.; Lucius, Ralph; Varoga, Deike; Wruck, Christoph J.; Jansen, Sandra; Podschun, Rainer; Pufe, Thomas; Brandenburg, Lars-Ove // Journal of Neuroinflammation;2011, Vol. 8 Issue 1, p11 

    Background: Recent studies have suggested that the scavenger receptor MARCO (macrophage receptor with collagenous structure) mediates activation of the immune response in bacterial infection of the central nervous system (CNS). The chemotactic G-protein-coupled receptor (GPCR)...

  • Carriage of Neisseria meningitidis Serogroup W135 ST-2881. Boisier, Pascal; Nicolas, Pierre; Djibo, Saacou; Hamidou, Amina Amadou; Tenebray, Bernard; Borrow, Raymond; Chanteau, Suzanne // Emerging Infectious Diseases;Sep2006, Vol. 12 Issue 9, p1421 

    Serogroup W135 ST-2881 meningococci caused a cluster of meningitis cases in Niger in 2003. Of 80 healthy persons in the patients' villages, 28 (35%) carried meningococci; 20 of 21 W135 carrier strains were ST-2881. Ten months later, 5 former carriers were still carriers of W135 ST-2881 strains....

  • Ex Vivo Bactericidal Activity against Group C Neisseria meningitidis in Seronegative Subjects. Gómez-Lus, M. L.; Aguilar, L.; Vázquez, J.; Giménez, M. J.; Ruiz, G.; Berrón, S.; Fuentes, F.; Prieto, J. // Infection;Oct2000, Vol. 28 Issue 5, p305 

    Background: To determine the anti-meningococcal C immunological activity by adding functional tests (opsonophagocytosis) to the classical serology techniques. Subjects and Methods: 42 adult volunteers were screened using serological methods (determination of total and bactericidal antibodies)....

  • Aplicación de una biblioteca de anticuerpos lineales humanos frente al polisacárido capsular de Neisseria meningitidis serogrupo B. León-Toirac, Emigdio; Camacho, Frank; Sarmiento, María Elena; Alerm, Alina; González, Domingo; González, Humberto; Acosta, Armando // Revista VacciMonitor (Vacunología y Temas Afines);sep-dic2013, Vol. 22 Issue 3, p28 

    Neisseria meningitidis serogroup B still produces a significant morbidity and mortality. Bacterial capsular polysaccharide in serogroup B shows structural homologies with human proteins and poor immunogenicity which make difficult the development of vaccines and polyclonal and monoclonal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics